New Strong Buy Stocks For July 24th
Zacks Investment Research | Jul 23, 2017 11:16PM ET
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aerie Pharmaceuticals Inc (AERI): This clinical-stage pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.5% over the last 30 days.
Agilent Technologies Inc (NYSE:A) (A): This provider of application focused solutions has seen the Zacks Consensus Estimate for its current year earnings improving 0.1% over the last 30 days.
Avista Corp (AVA): This electric and natural gas utility company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 0.7% over the last 30 days.
Chemours Co (CC): This provider of performance chemicals has seen the Zacks Consensus Estimate for its current year earnings surging 4.5% over the last 30 days.
Cryolife Inc (CRY): This medical device manufacturer and processor has witnessed the Zacks Consensus Estimate for its current year earnings improving 2.4% over the last 30 days.
CryoLife, Inc. Price and Consensus
he complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.